Episode

Special Edition: What's Next—Once-Weekly Insulin

Podcast
DOC Updates
Published
May 5, 2026
Duration seconds
1246
Processing state
not_requested
Canonical source
https://diabetescoreupdate.libsyn.com/special-edition-whats-nextonce-weekly-insulin
Audio
https://traffic.libsyn.com/secure/diabetescoreupdate/Whats_Next-Once_Weekly_Insulin.mp3?dest-id=159994
JSON
/v1/public/podcasts/doc-updates-200053/episodes/special-edition-what-s-next-once-weekly-insulin
Markdown
/podcast/doc-updates-200053/special-edition-what-s-next-once-weekly-insulin.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/doc-updates-200053/episodes/special-edition-what-s-next-once-weekly-insulin/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/doc-updates-200053/special-edition-what-s-next-once-weekly-insulin.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In the early 2000s, long-acting, once-daily insulin was approved, completely changing the experience of using insulin for people with diabetes. But science doesn't stand still. Now the FDA has approved weekly insulin. In this special episode of Diabetes Core Update , Neil Skolnik speaks with Athena Philis-Tsimikas, MD about this exciting development. This special edition of Diabetes Core Update is sponsored with support from Lilly . Please listen to the episodes by clicking on the podcast player below or by freely subscribing to Diabetes Core Update via Apple Podcasts , Amazon Music , Spotify , or your preferred podcast platform. Presented by: Neil Skolnik , MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Athena Philis-Tsimikas , MD, Corporate Vice President of the Scripps Whittier Diabetes Institute and Diabetes Care Line at Scripps Health in San Diego, CA